Amy L. Pasternak

572 total citations
27 papers, 212 citations indexed

About

Amy L. Pasternak is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Transplantation. According to data from OpenAlex, Amy L. Pasternak has authored 27 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 12 papers in Pharmacology and 9 papers in Transplantation. Recurrent topics in Amy L. Pasternak's work include Pharmacogenetics and Drug Metabolism (12 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Amy L. Pasternak is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Amy L. Pasternak collaborates with scholars based in United States and Cyprus. Amy L. Pasternak's co-authors include Daniel L. Hertz, Charis Eng, Angelika Erwin, Kristen M. Ward, Neil Mason, J. Kevin Hicks, Jennifer Hockings, Jasmine A. Luzum, Vicki L. Ellingrod and Jeong Mi Park and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Neuro-Oncology and Physiological Genomics.

In The Last Decade

Amy L. Pasternak

24 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy L. Pasternak United States	10	96	73	45	42	41	27	212
Rebecca Pulk United States	7	52 0.5×	45 0.6×	31 0.7×	34 0.8×	36 0.9×	14	172
Jennifer M. Skierka United States	6	130 1.4×	133 1.8×	8 0.2×	21 0.5×	63 1.5×	8	247
Shari Lennon United States	9	70 0.7×	84 1.2×	49 1.1×	69 1.6×	72 1.8×	11	471
Joseph H. Blommel United States	6	116 1.2×	74 1.0×	6 0.1×	18 0.4×	42 1.0×	10	234
Shripad Chitnis United States	6	18 0.2×	61 0.8×	72 1.6×	50 1.2×	30 0.7×	13	159
Eike Dazert Germany	6	58 0.6×	125 1.7×	24 0.5×	211 5.0×	45 1.1×	6	296
S. Asante-Poku Germany	4	72 0.8×	34 0.5×	8 0.2×	44 1.0×	67 1.6×	5	206
Mercè Brunet Spain	12	24 0.3×	43 0.6×	159 3.5×	24 0.6×	60 1.5×	24	422
Carin A.T.C. Lunenburg Netherlands	9	109 1.1×	50 0.7×	5 0.1×	226 5.4×	130 3.2×	12	358
Yusuke Hara Japan	11	58 0.6×	61 0.8×	11 0.2×	78 1.9×	193 4.7×	30	383

Countries citing papers authored by Amy L. Pasternak

Since Specialization

Citations

This map shows the geographic impact of Amy L. Pasternak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Pasternak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Pasternak more than expected).

Fields of papers citing papers by Amy L. Pasternak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Pasternak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Pasternak. The network helps show where Amy L. Pasternak may publish in the future.

Co-authorship network of co-authors of Amy L. Pasternak

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Pasternak. A scholar is included among the top collaborators of Amy L. Pasternak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Pasternak. Amy L. Pasternak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Jeong Mi, et al.. (2025). Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers. Pharmacogenomics. 26(3-4). 89–94.

Pasternak, Amy L., et al.. (2024). CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis. Pharmacogenetics and Genomics. 35(2). 81–86.

Pasternak, Amy L., Oxana Crysler, Paul Swiecicki, et al.. (2023). Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository. Clinical Pharmacology & Therapeutics. 114(2). 356–361. 1 indexed citations

Pasternak, Amy L., et al.. (2023). Risk of Toxicity From Topical 5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles. Clinical Pharmacology & Therapeutics. 115(3). 452–456. 2 indexed citations

Pasternak, Amy L., Jeong Mi Park, & Manjunath P. Pai. (2022). Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant Recipients. Therapeutic Drug Monitoring. 45(1). 95–101. 3 indexed citations

Leino, Abbie D., Jeong Mi Park, & Amy L. Pasternak. (2021). Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(8). 649–657. 7 indexed citations

Pasternak, Amy L., Vincent D. Marshall, Christina L. Gersch, et al.. (2021). Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus. Pharmacogenomics and Personalized Medicine. Volume 14. 319–326. 9 indexed citations

Fang, Fang, et al.. (2021). SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate. Pharmacogenomics. 22(17). 1111–1120. 2 indexed citations

Fang, Fang, Jung Won Kwon, Kyo-in Koo, et al.. (2021). Patients Carrying DPYD Variant Alleles have Increased Risk of Severe Toxicity and Related Treatment Modifications During Fluoropyrimidine Chemotherapy. Pharmacogenomics. 22(3). 145–155. 10 indexed citations

10.

Pasternak, Amy L., Yajing Li, Vy Kim Nguyen, et al.. (2021). Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy. Transplantation and Cellular Therapy. 28(1). 19.e1–19.e7. 9 indexed citations

11.

Pasternak, Amy L., et al.. (2020). Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources. npj Genomic Medicine. 5(1). 48–48. 18 indexed citations

12.

Hockings, Jennifer, Amy L. Pasternak, Angelika Erwin, et al.. (2020). Pharmacogenomics: An evolving clinical tool for precision medicine. Cleveland Clinic Journal of Medicine. 87(2). 91–99. 39 indexed citations

13.

Ward, Kristen M., et al.. (2020). Teaching psychiatric pharmacogenomics effectively: Evaluation of a novel interprofessional online course. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(2). 176–183. 4 indexed citations

14.

Pasternak, Amy L., et al.. (2020). Impact of the MTHFR C677T genetic variant on depression. 19(10). 1 indexed citations

15.

Ward, Kristen M., et al.. (2020). Assessing the knowledge, perceptions, and practices of primary care clinicians toward pharmacogenetics. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(1). 27–32. 5 indexed citations

16.

Pasternak, Amy L., et al.. (2019). Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implications. The Pharmacogenomics Journal. 19(6). 501–515. 17 indexed citations

17.

Pasternak, Amy L., Kelley M. Kidwell, Christina L. Gersch, et al.. (2019). Impact of CYP3A5 Phenotype on Tacrolimus Concentrations After Sublingual and Oral Administration in Lung Transplant. Pharmacogenomics. 20(6). 421–432. 8 indexed citations

18.

Linzey, Joseph R., Bernard L. Marini, Amy L. Pasternak, et al.. (2017). Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology. Journal of Neuro-Oncology. 137(1). 155–169. 10 indexed citations

19.

Hertz, Daniel L., Jasmine A. Luzum, Amy L. Pasternak, et al.. (2017). Institutional Profile of Pharmacogenetics within University of Michigan College of Pharmacy. Pharmacogenomics. 18(12). 2 indexed citations

20.

Pasternak, Amy L., Kristine R. Crews, Kelly E. Caudle, et al.. (2016). The Impact of the UGT1A1*60 Allele on Bilirubin Serum Concentrations. Pharmacogenomics. 18(1). 5–16. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact